Submission of Annual Report for FY 2024-25 and intimation of voting through electronic means
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has submitted its Annual Report for the financial year 2024-25 to the stock exchange as part of routine compliance. Along with this, the company has informed shareholders about the facility to vote through electronic means (e-voting) for the upcoming Annual General Meeting. Shareholders can now access the annual report and cast their votes online within the stipulated time window. This is a standard regulatory disclosure required before the AGM.
This is a routine compliance filing with no direct impact on stock price or business operations. Shareholders should review the annual report and use the e-voting facility to participate in AGM resolutions.